XMAB 5592: A DEEP DIVE INTO ITS MECHANISM AND POTENTIAL

This innovative antibody, XmAb 5592, presents a distinct mechanism of action targeting IL17A with high potency. Differing from conventional antibodies, it operates as a bipartite modulator, binding to both the antigen and its control domain, leading to suppression of IL-17A production and biolog